These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 25785527)

  • 1. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
    Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
    Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
    Utsunomiya T; Kawahara A; Hanada K; Yoshida A
    Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diquafosol ophthalmic solution for dry eye treatment.
    Nakamura M; Imanaka T; Sakamoto A
    Adv Ther; 2012 Jul; 29(7):579-89. PubMed ID: 22843206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
    Park DH; Chung JK; Seo DR; Lee SJ
    Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
    Shigeyasu C; Yamada M; Akune Y; Tsubota K
    Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.
    Keating GM
    Drugs; 2015 May; 75(8):911-22. PubMed ID: 25968930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis.
    Toda I; Ide T; Fukumoto T; Ichihashi Y; Tsubota K
    Am J Ophthalmol; 2014 Mar; 157(3):616-22.e1. PubMed ID: 24528935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore.
    Gong L; Sun X; Ma Z; Wang Q; Xu X; Chen X; Shao Y; Yao K; Tang L; Gu Y; Yuan H; Chua WH; Chuan JC; Tong L
    Br J Ophthalmol; 2015 Jul; 99(7):903-8. PubMed ID: 25631485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis.
    Mori Y; Nejima R; Masuda A; Maruyama Y; Minami K; Miyata K; Amano S
    Cornea; 2014 Jul; 33(7):659-62. PubMed ID: 24858017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials.
    Wu D; Chen WQ; Li R; Wang Y
    Cornea; 2015 Jun; 34(6):644-50. PubMed ID: 25909234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
    Jeon HS; Hyon JY
    J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye.
    Ueda K; Matsumiya W; Otsuka K; Maeda Y; Nagai T; Nakamura M
    BMC Ophthalmol; 2015 Jun; 15():58. PubMed ID: 26048396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye.
    Koh S; Maeda N; Ikeda C; Oie Y; Soma T; Tsujikawa M; Watanabe H; Nishida K
    Acta Ophthalmol; 2014 Dec; 92(8):e671-5. PubMed ID: 24863298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
    Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
    Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Clinic-based Survey of Clinical Characteristics and Practice Pattern of Dry Eye in Japan.
    Kawashima M; Yamada M; Suwaki K; Shigeyasu C; Uchino M; Hiratsuka Y; Yokoi N; Tsubota K;
    Adv Ther; 2017 Mar; 34(3):732-743. PubMed ID: 28181147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Topical Diquafosol Tetrasodium Treatment of Dry Eye Disease Caused by Chronic Graft-Versus-Host Disease: A Retrospective Study.
    Yamane M; Ogawa Y; Fukui M; Kamoi M; Uchino M; Saijo-Ban Y; Kozuki N; Mukai S; Mori T; Okamoto S; Tsubota K
    Eye Contact Lens; 2018 Nov; 44 Suppl 2():S215-S220. PubMed ID: 29280750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye.
    Koh S; Ikeda C; Takai Y; Watanabe H; Maeda N; Nishida K
    Jpn J Ophthalmol; 2013 Sep; 57(5):440-6. PubMed ID: 23740285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing two mucin secretagogues for the treatment of dry eye disease: a prospective randomized crossover trial.
    Jin Y; Seo KY; Kim SW
    Sci Rep; 2024 Jun; 14(1):13306. PubMed ID: 38858411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.